UC Davis Medical Center is home to one of only 49 National Cancer Institute (NCI) designated comprehensive cancer centers. The UC Davis Center is the only comprehensive cancer center in California’s Central Valley and inland northern California. It serves a region with a population of roughly 6 million people. The Center has $63 million in NHI and California Healthcare Institute funding.
The NCI, a division of the NIH, awards University of California, Davis roughly $200 million annually to conduct cancer research.
Here are the top 5 NCI grants this year:
Read More
Tags:
CA,
University of California Davis Medical Center,
Southwest,
NIH funded Research Projects,
UCDMC,
BioResearch Product Faire Event,
biotech vendor show,
Sacramento,
cancer research funding,
Comprehensive Cancer Center,
Oncology,
Cancer Immunotherapy,
Cancer Science
UC Davis School of Medicine in Sacramento ranked in the top 20 percent of national medical schools for research funding by the National Institute of Health (NIH). According to the 2017 report issued by the Blue Ridge Institute for Medical Research, the school received $176 million to fund 356 grant proposals last year. This placed UC Davis at 26th in the nation for NIH funding.
Read More
Tags:
CA,
University of California Davis Medical Center,
Southwest,
UCDMC,
BioResearch Product Faire Event,
Research Funding,
Sacramento,
NIH funding,
2018,
NIH awards 2017,
nih research funding
Last Fall, UC Davis' Comprehensive Cancer Center received its first National Cancer Institute (NCI) Moonshot Grant of $2.5 million to research two types of cancers in dogs that are very similar to cancer in humans.
UC Davis boasts both a world renowned veterinary school and medical school. Researchers are equipped with the tools to examine the link between cancer in dogs and cancer in humans. UC Davis has a Comparative Oncology Program at the Comprehensive Cancer Center, one of very few in the nation.
The program allows for veterinarians and physicians to work together to find creative cancer solutions. Robert Canter, a surgical oncologist at the Davis Comprehensive Cancer Center, and Robert Rehun, a veterinary oncologist, plan to conduct various research trials with the Moonshot Grant.
The trials will be focused on isolating dogs' natural killer cells. Killer cells are white blood cells that are particulary good at eliminating cells infected with viruses or cancer cells. Once the killer cells are isolated, researchers hope to connect the killer cells with human IL15. IL15 is a cytokine that might help activate the killer cells in human patients.
This study is just one example of the many different projects that UC Davis facilitates to help advance cancer research. This past year, the Davis Comprehensive Cancer Center received $7.3 million in support. The Biomedical Technology Program at the Cancer Center alone has over 20 active projects and almost $24 million in funding.
Read More
Tags:
CA,
University of California Davis Medical Center,
Southwest,
UCDMC,
BioResearch Product Faire Event,
Sacramento,
2018,
Oncology,
Cancer Immunotherapy
White blood cells help the immune system protect the body from infections and diseases. Along with attacking infections, white blood cells also have the ability to bring other cells together to help in the fight. With these known abilities of white blood cells, life science researchers have been researching ways to amplify the abilities of these cells to target specific illnesses, such as tumors.
Read More
Tags:
CA,
University of California Davis Medical Center,
University of California Davis,
Cancer Treatment,
Immune System,
UCDMC,
Sacramento,
NIH funding,
2018
The University of California, Davis Medical Center is one of the highest funded research institutions in California. The university recently received two new grants from the California Institute for Regenerative Medicine (CIRM), totaling $3.2 million, which will be used to support two research projects focusing on treating cancer and other diseases.
Read More
Tags:
CA,
University of California Davis Medical Center,
Southwest,
UCDMC,
BioResearch Product Faire Event,
Sacramento,
CIRM,
new funding,
UC Davis,
2016,
California Institutes of Regenerative Medicine
The University of California, Davis Medical Center is one of the best in the country. It is comprised of the UC Davis Cancer Center, a medical school, the MIND (Medical Investigation of Neurodevelopmental Disorders) Institute, the Eye Center, and other important research facilities. Recently, the medical center received a generous donation to aid their research.
Read More
Tags:
CA,
University of California Davis Medical Center,
Optics,
Southwest,
UCDMC,
Sacramento,
new funding,
UC Davis,
2016,
BioResearch Product Faire,
Ernest E. Tschannen,
eye center,
West Coast
Alzheimer's is a devastating disease known to cause memory loss, thinking and behavioral problems that worsen over time. Currently Alzheimer's does not have any known cures, but Alzheimer's disease is heavily studied by researchers across the nation, and millions of dollars are given to Alzheimer's researchers annually to work towards better understanding the onset and function of the disease to lead to potential treatments and cures.
Read More
Tags:
CA,
University of California Davis Medical Center,
Southwest,
Alzheimer's Research,
UCDMC,
BioResearch Product Faire Event,
Sacramento,
2016
This prestigious designation makes the MIND Institute one of only fifteen Intellectual and Developmental Disabilities Research Centers in the country. Transition into this program is made possible by a five-year $6.5 million NIH grant and gives the institute critical new resources that will accelerate its progress in neurodevelopment research.
Tags:
University of California Davis Medical Center,
Bioinformatics,
neurodevelopmental disorders,
assays,
molecular biology imaging,
biological analysis,
immunoassays,
environmental contaminants,
Autism,
UCDMC,
Funding,
Research,
NIH,
UC Davis,
UCD,
grant,
drug evaluation,
developmental disabilities
An historic collaboration between the University of California Davis and China's BGI, the world’s largest genomics organization, has dramatically increased the University's genome sequencing capabilities and promises to open up altogether new research opportunities in the life sciences community with genomic studies of plants, animals, humans and microbes. The new joint endeavor is called BGI@UC Davis and will benefit both UCD and China's first citizen-managed, non-profit research institution.
Tags:
2014,
University of California Davis Medical Center,
2013,
University of California Davis,
New research facilities,
Southwest,
California,
University of California,
UCDMC,
BioResearch Product Faire Event,
Genomics,
genomics research,
Sacramento,
Davis,
Sacramento Campus,
UCD
